Prospective single-center study of multimodality imaging and omics data analysis to evaluate cardiac function and risk factors in breast cancer patients treated with chemothrapy

Prospective single-center study of multimodality imaging and omics data analysis to evaluate cardiac function and risk factors in breast cancer patients treated with chemothrapy - CHECK HEART BC-omics

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038875

Enrollment

500

Registered

2020-01-01

Start date

2020-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Drug-induced cardiomyopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)Patients who will receive chemotherapy in medical institutions for clinical trials. (2)Informed consent in writing.

Exclusion criteria

Exclusion criteria: (1)Patients who are judged irrelevant to this clinical trial by the attending doctor.

Design outcomes

Primary

Measure	Time frame
Incidence of cardiotoxicity after the treatment for breast cancer(a drop in LVEF of > 10% from baseline and < 53%). The results of omics data analysis.	—

Secondary

Measure	Time frame
ncidence of symptomatic heart failure or any other cardiac event after the treatment for breast cancer.	—

Countries

Japan

Contacts

Public ContactNochioka Kotaro

Tohoku University Department of Cardiovascular medicine

nochioka@cardio.med.tohoku.ac.jp022-717-7153

Outcome results